Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches
Theranostics · 2024 · 14 (1) · 379-391
DOI: 10.7150/thno.89495 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Shiqi Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi 710…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Endosialin, also known as tumor endothelial marker 1 (TEM1) or CD248, is a single transmembrane glycoprotein with a C-type lectin-like domain. Endosialin is mainly expressed in the stroma, especially in cancer-associated fibroblasts and pericytes, in most solid tumors. Endosialin is also expressed in tumor cells of most sarcomas. Endosialin can promote tumor progression through different mechanisms, such as promoting tumor cell proliferation, adhesion and migration, stimulating tumor angiogenesis, and inducing an immunosuppressive tumor microenvironment. Thus, it is considered an ideal target for cancer treatment. Several endosialin-targeted antibodies and therapeutic strategies have been developed and have shown preliminary antitumor effects. Here, we reviewed the endosialin expression pattern in different cancer types, discussed the mechanisms by which endosialin promotes tumor progression, and summarized current therapeutic strategies targeting endosialin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
- Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
Zitieren
APA
Lu, S., Gan, L., Lu, T., Zhang, K., Zhang, J., Wu, X., Han, D., Xu, C., Liu, S., Yang, F., Qin, W., & Wen, W. (2024). Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches. Theranostics, 14(1), 379-391. https://doi.org/10.7150/thno.89495
Vancouver
Lu S, Gan L, Lu T, Zhang K, Zhang J, Wu X, et al. Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches. Theranostics. 2024;14(1):379-391. doi:10.7150/thno.89495
BibTeX
@article{Lu2024,
author = {Lu, Shiqi and Gan, Lunbiao and Lu, Tong and Zhang, Keying and Zhang, Jiayu and Wu, Xinjie and Han, Donghui and Xu, Chao and Liu, Shaojie and Yang, Fa and Qin, Weijun and Wen, Weihong},
title = {Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {1},
pages = {379--391},
doi = {10.7150/thno.89495}
}
EUVIMED